Amicus Q4 revenue beats estimates
Overview
Biotechnology firm's Q4 revenue rose 24%, beating analyst expectations
Adjusted EPS for Q4 beat analyst expectations
Outlook
Company will not provide financial guidance for 2026 due to pending acquisition
Result Drivers
GALAFOLD SALES - Driven by commercial execution, new patient starts, and strong compliance
POMBILITI + OPFOLDA SALES - High demand from established and new markets drove growth
CASH POSITION - Increased by $44M, reflecting operational growth
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q4 Revenue | Beat | $185.20 mln | $180.69 mln (9 Analysts) |
Q4 Adjusted EPS | Beat | $0.10 | $0.09 (8 Analysts) |
Q4 EPS |
| $0.01 |
|
Q4 Net Income |
| $1.70 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 7 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the biotechnology & medical research peer group is "buy."
Wall Street's median 12-month price target for Amicus Therapeutics Inc is $14.50, about 1% above its February 19 closing price of $14.35
The stock recently traded at 45 times the next 12-month earnings vs. a P/E of 40 three months ago
Press Release: ID:nGNX8znCKR
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
Related Articles
Will Bank of England Still Cut Rates in 2026? Falling Inflation Favors Loose Monetary Policy, Pound Exchange Rate May Struggle to Sustain Strength.
TradingKey - The outlook for the British Pound in 2026 is undoubtedly one of the most significant focal points for investors in the FX market. Following a structural shift in 2025 characterized by a "low start and high finish," GBP/USD successfully broke out of its two-year trading range and stabilized near 1.35 at year-end, laying the foundation for its performance in 2026.
What Is the Best Nuclear Energy Investment in 2026? Which Should You Buy in, OKLO or Nuclear Energy ETFs?
TradingKey - Demand for electricity is surging, and data centers designed for artificial intelligence are a big reason. Governments are also demanding cleaner, dependable power. This coupling has brought about a revival in nuclear power, with capacity expected to increase in the coming decades. To i
Stock Market Crash 2026: What Fed Signals and Economic Data Mean for Investors
TradingKey - The possibility of a stock market crash occurring in 2026 is becoming increasingly likely as investor sentiment continues to decline.
New Fed Chair Warsh Takes Office: Major Shift in Monetary Policy? US Dollar Short-Term Rebound, 2026 Investment Strategy Analysis
TradingKey - At the start of 2026, global financial markets witnessed a major leadership change as U.S. President Trump officially nominated Kevin Warsh as the next Federal Reserve Chair. Pending Senate confirmation, he will succeed Jerome Powell this May to lead the world’s most influential central bank.
